CD6 and myeloid sarcoma: In a recent study, we validated the association of four risk single nucleotide polymorphisms (SNPs) with MS susceptibility [5], in a northern Spanish-Basque population, from which the CD6 SNP rs17824933 emerged with a stronger risk (OR = 1.34) [18].